Skip to content

Shanghai Bio-heart Biological Technology Co Ltd Sustainability Reports

The company is a medical device company primarily engaged in the research, development, and commercialization of interventional cardiovascular devices. Its core product candidates include bioresorbable scaffolds for percutaneous coronary intervention procedures and renal denervation systems for treating hypertension.

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

FIGI: BBG013JZV054

5 reports from 2021 to 2025